Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4460352
Max Phase: Preclinical
Molecular Formula: C31H42N4O4
Molecular Weight: 534.70
Molecule Type: Unknown
Associated Items:
ID: ALA4460352
Max Phase: Preclinical
Molecular Formula: C31H42N4O4
Molecular Weight: 534.70
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@@H](Oc2ccccc2)[C@H]1C(=O)N[C@H]1CCCc2ccccc21)C(C)(C)C
Standard InChI: InChI=1S/C31H42N4O4/c1-20(32-5)28(36)34-27(31(2,3)4)30(38)35-19-18-25(39-22-14-7-6-8-15-22)26(35)29(37)33-24-17-11-13-21-12-9-10-16-23(21)24/h6-10,12,14-16,20,24-27,32H,11,13,17-19H2,1-5H3,(H,33,37)(H,34,36)/t20-,24-,25+,26-,27+/m0/s1
Standard InChI Key: SDDMSHTWVZCZTR-XZBVMJHXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 534.70 | Molecular Weight (Monoisotopic): 534.3206 | AlogP: 3.37 | #Rotatable Bonds: 8 |
Polar Surface Area: 99.77 | Molecular Species: BASE | HBA: 5 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.37 | CX Basic pKa: 8.60 | CX LogP: 3.64 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.48 | Np Likeness Score: 0.06 |
1. Cong H, Xu L, Wu Y, Qu Z, Bian T, Zhang W, Xing C, Zhuang C.. (2019) Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives., 62 (12): [PMID:30676015] [10.1021/acs.jmedchem.8b01668] |
Source(1):